Pancreatic tissue HMGB1 levels are significantly increased in experimental SAP [44]; HMGB1 promotes the pathogenesis of pancreatitis [39, 45], and inhibiting HMGB1 therapy ameliorates the pancreatic injury [46]. This evidence concerns the gene HMGB1 and pancreatitis.